These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34359784)

  • 1. Streamlined Schemes for Dosimetry of
    Kurth J; Heuschkel M; Tonn A; Schildt A; Hakenberg OW; Krause BJ; Schwarzenböck SM
    Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ and tumor dosimetry including method simplification for [
    Karimzadeh A; Schatz L; Sauer M; Apostolova I; Buchert R; Klutmann S; Lehnert W
    EJNMMI Phys; 2024 Jul; 11(1):63. PubMed ID: 39017988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetry for (177)Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer.
    Delker A; Fendler WP; Kratochwil C; Brunegraf A; Gosewisch A; Gildehaus FJ; Tritschler S; Stief CG; Kopka K; Haberkorn U; Bartenstein P; Böning G
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):42-51. PubMed ID: 26318602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [
    Kurth J; Krause BJ; Schwarzenböck SM; Bergner C; Hakenberg OW; Heuschkel M
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):123-135. PubMed ID: 31482426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation.
    Peters SMB; Mink MCT; Privé BM; de Bakker M; de Lange F; Muselaers CHJ; Mehra N; Witjes JA; Gotthardt M; Nagarajah J; Konijnenberg MW
    EJNMMI Res; 2023 Jan; 13(1):6. PubMed ID: 36692682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT.
    Gosewisch A; Ilhan H; Tattenberg S; Mairani A; Parodi K; Brosch J; Kaiser L; Gildehaus FJ; Todica A; Ziegler S; Bartenstein P; Böning G
    EJNMMI Res; 2019 Aug; 9(1):76. PubMed ID: 31414241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation Dosimetry for
    Okamoto S; Thieme A; Allmann J; D'Alessandria C; Maurer T; Retz M; Tauber R; Heck MM; Wester HJ; Tamaki N; Fendler WP; Herrmann K; Pfob CH; Scheidhauer K; Schwaiger M; Ziegler S; Eiber M
    J Nucl Med; 2017 Mar; 58(3):445-450. PubMed ID: 27660138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The
    Maffey-Steffan J; Scarpa L; Svirydenka A; Nilica B; Mair C; Buxbaum S; Bektic J; von Guggenberg E; Uprimny C; Horninger W; Virgolini I
    Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):695-712. PubMed ID: 31776632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-therapeutic dosimetry of normal organs and tissues of (177)Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer.
    Kabasakal L; AbuQbeitah M; Aygün A; Yeyin N; Ocak M; Demirci E; Toklu T
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):1976-83. PubMed ID: 26227531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT.
    Grob D; Privé BM; Muselaers CHJ; Mehra N; Nagarajah J; Konijnenberg MW; Peters SMB
    EJNMMI Phys; 2024 Apr; 11(1):34. PubMed ID: 38568428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA
    Gosewisch A; Delker A; Tattenberg S; Ilhan H; Todica A; Brosch J; Vomacka L; Brunegraf A; Gildehaus FJ; Ziegler S; Bartenstein P; Böning G
    EJNMMI Res; 2018 Aug; 8(1):76. PubMed ID: 30076556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different methods for post-therapeutic dosimetry in [
    Rosar F; Schön N; Bohnenberger H; Bartholomä M; Stemler T; Maus S; Khreish F; Ezziddin S; Schaefer-Schuler A
    EJNMMI Phys; 2021 May; 8(1):40. PubMed ID: 33950333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney absorbed radiation doses for [ 177 Lu]Lu-PSMA-617 and [ 177 Lu]Lu-PSMA-I&T determined by 3D clinical dosimetry.
    Uijen MJM; Privé BM; van Herpen CML; Westdorp H; van Gemert WA; de Bakker M; Gotthardt M; Konijnenberg MW; Peters SMB; Nagarajah J
    Nucl Med Commun; 2023 Apr; 44(4):270-275. PubMed ID: 36597884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetry of
    Violet J; Jackson P; Ferdinandus J; Sandhu S; Akhurst T; Iravani A; Kong G; Kumar AR; Thang SP; Eu P; Scalzo M; Murphy D; Williams S; Hicks RJ; Hofman MS
    J Nucl Med; 2019 Apr; 60(4):517-523. PubMed ID: 30291192
    [No Abstract]   [Full Text] [Related]  

  • 15. Dosimetry and safety of
    Paganelli G; Sarnelli A; Severi S; Sansovini M; Belli ML; Monti M; Foca F; Celli M; Nicolini S; Tardelli E; Marini I; Matteucci F; Giganti M; Di Iorio V; De Giorgi U
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3008-3017. PubMed ID: 32430583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T.
    Brosch-Lenz J; Uribe C; Gosewisch A; Kaiser L; Todica A; Ilhan H; Gildehaus FJ; Bartenstein P; Rahmim A; Celler A; Ziegler S; Böning G
    EJNMMI Phys; 2021 Mar; 8(1):26. PubMed ID: 33709253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative imaging for
    Meyer C; Szidonya L; Winters C; Mench A; Mallak N; Mittra E
    Front Nucl Med; 2023; 3():1291253. PubMed ID: 39355047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after
    Völter F; Mittlmeier L; Gosewisch A; Brosch-Lenz J; Gildehaus FJ; Zacherl MJ; Beyer L; Stief CG; Holzgreve A; Rübenthaler J; Cyran CC; Böning G; Bartenstein P; Todica A; Ilhan H
    Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33802417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-Specific Dosimetry in Radioligand Therapy (RLT) for Metastatic Prostate Cancer Using
    Mahmoudi E; Pirayesh E; Deevband MR; Amoui M; Rad MG; Ghorbani M
    Nucl Med Mol Imaging; 2021 Oct; 55(5):237-244. PubMed ID: 34721716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of Critical Organ Doses with
    Yilidir G; Demir M
    J Med Phys; 2024; 49(2):304-310. PubMed ID: 39131436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.